Home / Curated GI articles May 13th, 2021: Gut health company Zoe lands $20M in funding
CMS 2021 Final Rule: What practices can do (Physicians Practice)
Justin Chamblee, CPA and senior vice president of Coker Group, gave a presentation overviewing CMS’s 2021 Final Rule changes and exploring the impact these changes will have on wRVUs and physician compensation.
14 Takeaways from Exact Sciences quarterly earnings call (NextServices)
The company expects to make $1.7 billion in revenues in 2021. COVID-19 testing contributed to $32.3 million.
Nurse Practitioners Trained to Perform Colonoscopies Viewed as Exploiting Black Patients (DocWireNews)
Approximately seventy-five percent of the patients to receive the colonoscopy from an NP were black, John Hopkins’ researchers attempt to improve diversity in their clinical trials.
WELL’s CRH Medical Announces Acquisition of New England Anesthesia Associates (PRNewswire)
Acquisition adds 17 practitioners to CRH’s team which now exceeds 800 healthcare practitioners who are predominantly credentialed anesthesia providers.
Gut health company ZOE lands $20M to speed up program rollout (mobiHealthNews)
Based on the results of ZOE’s at-home gut health, blood sugar and blood fat tests, the company creates a personalized dietary plan for its users.
CRH Medical moves into Connecticut with new acquisition (Becker’s GI & Endoscopy)
The company has an 85 percent stake in New England Anesthesia Associates, which provides services to an ASC in Guilford, Conn.
AGA Clinical Practice Update: Management of Bleeding Gastric Varices (Medscape)
When classifying gastric varices during endoscopy, experts suggest not only describing their location but also their size and whether any high-risk stigmata, such as discolorations and platelet plugs, are present.
Meet the new CEO of OneGI (Becker’s GI & Endoscopy)
Robbie Allen will be CEO of OneGI, a private-equity backed gastroenterology platform. Here are four things to know.
Early-Onset Colorectal Cancer — Are Sugary Drinks to Blame? (Medscape)
The study found that women who recalled drinking two or more SSB per day in young adulthood had a twofold increase in the risk of colorectal cancer before the age of 50.
First new treatment in decades for patients with rare form of bowel cancer (The Herald)
The Scottish Medicines Consortium has given the go ahead for Braftovi to be used in combination with cetuximab in patients whose cancer has the BRAF V600 genetic mutation.
3 tips for GI success: Q&A with Linda Lee (Becker’s GI & Endoscopy)
Linda Lee, MD, the medical director of endoscopy for Boston-based Brigham and Women’s Hospital, spoke with Becker’s ASC Review to give tips for gastrointestinal practices to succeed in the next two years.
Model Finds Stool Tests Key to Lowering CRC Screening Age (Gastroenterology & Endoscopy News)
A new modeling study suggests that use of stool-based tests in younger people could reduce the incidence of the disease and save lives, even when adherence is less than perfect.
Topol Talks: COVID-19 Variants Are Innocent Until Proven Guilty (Medscape)
Eric Topol, MD spoke with writer Miriam E. Tucker about the latest on SARS-CoV-2 variants and their impact on vaccine efficacy.
Video: Dr. Basu-Mallick on Established and Emerging Biomarker-Directed Therapies in CRC (ONC Live)
Approximately 40% of patients with CRC have KRAS wild-type disease and are able to receive treatment with established therapies such as cetuximab (Erbitux) and panitumumab (Vectibix), Basu-Mallick says.
More Hot headlines in GI